While it is common to hear that drug developers are in the early stages of integrating artificial intelligence with their drug research, discovery, and development efforts, one Bristol Myers Squibb ...
Bristol Myers Squibb delivered better than expected fourth quarter earnings, but Eliquis missed expectations while Cobenfy ...
Pharmaceutical Technology on MSN
BMS reports flat revenue growth for full-year 2025
The company projects 2026 revenues between $46.0bn and $47.5bn, with non-GAAP EPS ranging from $6.05 to $6.35.
The battery market is heating up. In the United States, the Inflation Reduction Act has added to the growing momentum by offering electric-car tax credits as well as making billions of dollars ...
In battery-management systems (BMS), connectivity to the host, the charger, other externally connected devices, and the battery’s components is becoming essential. How many CAN networks can be used by ...
Lewes, Delaware, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The Global Battery Management System (BMS) Market Size is projected to grow at a CAGR of 19.86% from 2024 to 2031, according to a new report ...
Bristol Myers Squibb (NYSE: BMY; BMS) beat analyst consensus forecasts by reporting higher than expected numbers for total revenue and its “growth” portfolio of drugs on which BMS is counting on for ...
Details on a BMS based on electrochemical impedance spectroscopy (EIS). BMS advances to keep pace with EV rising complexity. Building better battery models based on EIS characterization. The ...
OXB and Bristol Myers Squibb (BMS) are expanding a partnership regarding manufacture and supply of lentiviral vectors for BMS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results